GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XSWX:NWRN) » Definitions » 3-Year Dividend Growth Rate

Newron Pharmaceuticals SpA (XSWX:NWRN) 3-Year Dividend Growth Rate : 0.00% (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Newron Pharmaceuticals SpA 3-Year Dividend Growth Rate?

Newron Pharmaceuticals SpA's Dividends per Share for the six months ended in Dec. 2023 was CHF0.00.

The historical rank and industry rank for Newron Pharmaceuticals SpA's 3-Year Dividend Growth Rate or its related term are showing as below:

XSWX:NWRN's 3-Year Dividend Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 14.5
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Newron Pharmaceuticals SpA's Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00. As of today, Newron Pharmaceuticals SpA's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Newron Pharmaceuticals SpA's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, Newron Pharmaceuticals SpA's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Newron Pharmaceuticals SpA's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Newron Pharmaceuticals SpA's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Newron Pharmaceuticals SpA's 3-Year Dividend Growth Rate falls into.



Newron Pharmaceuticals SpA 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Newron Pharmaceuticals SpA  (XSWX:NWRN) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Newron Pharmaceuticals SpA's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ -0.49
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Newron Pharmaceuticals SpA 3-Year Dividend Growth Rate Related Terms>


Newron Pharmaceuticals SpA (XSWX:NWRN) Business Description

Traded in Other Exchanges
Address
Via Antonio Meucci 3, Bresso, Milan, ITA, 20091
Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.
Executives
Patrick Langlois Supervisory Board

Newron Pharmaceuticals SpA (XSWX:NWRN) Headlines

No Headlines